NOCIL earnings calls.
Other · 2 quarters tracked · source-linked performance, management guidance and promise context.
Latest revenue
₹330 Cr
verified financial record
Quarters tracked
2
source records in the directory
Delivery assessment
0
Across 2 tracked commitments: 0 delivered, 2 missed.
Call date
2026-05-15
latest available source date
Signal trajectory
2 actual quartersCurrent read
0/100
Across 2 tracked commitments: 0 delivered, 2 missed.
Latest source read
What changed this quarter?
NOCIL's Q4 FY26 revenue of ₹330 crore grew 5% sequentially, with volumes up 7% QoQ, driven by GST 2.0-led domestic demand and steady international traction. However, EBITDA margin contracted to 6.4% due to inventory effects and rising raw material costs, while PAT improved to ₹17 crore from ₹9 crore in Q3. Management expects double-digit volume growth in FY27, supported by new capacity at H (trial production started) and a ₹130 crore specialty capex for H1 FY28. Pricing power is returning: non-contractual prices were raised in March, and contractual revisions are underway. Anti-dumping duty recommendations for TDQ and sulfenamides await government approval, which could improve spreads. Key risk: persistent low-priced imports from FTA countries may delay margin recovery despite anti-dumping measures.
Colored figures compare against the previous available record. Hover or focus one for the comparison.
Signal
Watch
Revenue
₹330 Cr
Source date
2026-05-15
Across the record
Quarter history.
History modules